Partial least squares Discriminant analysis on MS studies

This analysis uses the "muma" package of the R statistics environment (Reference)

Click on links below to perform analysis.

PLSDA	Study ID	Scaling	Study Title	MS Analysis Type
	ST003388	Auto Pareto Vast Median Range None	RMC-113 (dual-lipid kinase inhibitor, PIKfyve, PIP4K2C) alters the phosphoinositide regioisomer signature by advanced lipidomics analysis	Reversed phase POSITIVE ION MODE